Rationally designed redirection of natural killer cells anchoring a cytotoxic ligand for pancreatic cancer treatment
Young Eun Lee(Korea University), Mihue Jang(Kyung Hee University), Anna Ju(Chung-Ang University), Hyo Jeong Kang(Asan Medical Center), Song Cheol Kim(Ulsan College), Hwi Wan Choi(Ulsan College), Eunsung Jun(Asan Medical Center), Jin‐Young Jang(Seoul National University), Tae Sung Kim(Pusan National University Dental Hospital), Jinchul Kim(Samsung Medical Center), Ja‐Lok Ku(Seoul National University), Sang-Yeob Kim(Ulsan College), Eunice EunKyeong Kim(Korea Institute of Science and Technology)
Cited by 55
Related Papers
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
|Proceedings of the National Academy of Sciences|2017|577
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
|Gastroenterology|2015|472
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
|JNCI Journal of the National Cancer Institute|2019|299
A 3D-printed local drug delivery patch for pancreatic cancer growth suppression
|Journal of Controlled Release|2016|260
Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel
|Clinical Cancer Research|2019|237